Shengchang Yang (Bingbing Liu)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Signaling Pathway

Top Venues

Pharmaceutical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Bingbing Liu, Jianchao Si, Kerong Qi, Dongli Li, Tingting Li, Yi Tang, Ensheng Ji, Shengchang Yang
Chronic intermittent hypoxia aggravated diabetic cardiomyopathy through LKB1/AMPK/Nrf2 signaling pathway. PloS one 19 (3) (2024)
Bingbing Liu, Jianchao Si, Kerong Qi, Dongli Li, Tingting Li, Yi Tang, Ensheng Ji, Shengchang Yang
Chronic intermittent hypoxia aggravated diabetic cardiomyopathy through LKB1/AMPK/Nrf2 signaling pathway. PloS one 19 (3) (2024)
Bingbing Liu, Jianchao Si, Kerong Qi, Dongli Li, Tingting Li, Yi Tang, Ensheng Ji, Shengchang Yang
Chronic intermittent hypoxia aggravated diabetic cardiomyopathy through LKB1/AMPK/Nrf2 signaling pathway. PloS one 19 (3) (2024)
Dongli Li, Jianchao Si, Ya-Jing Guo, Shengchang Yang, Xue Chen, Kerong Qi, Shengchang Yang, Ensheng Ji
Danggui-Buxue decoction alleviated vascular senescence in mice exposed to chronic intermittent hypoxia through activating the Nrf2/HO-1 pathway. Pharmaceutical biology 61 (1) (2023)